Aerobic and lung performance in premature children with and without chronic lung disease of prematurity.

Clin J Sport Med

Children's Exercise and Nutrition Centre, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.

Published: September 2005

Objective: This study intended to identify pulmonary and exercise-related effects of chronic lung disease of infancy (CLD) versus prematurity (PRE) without CLD in children 5 to 7 years old who were born prematurely (24-30 weeks of gestation) with very low and extremely low birthweight of 500 to 1500 g (VLBW, ELBW).

Subjects: Seventeen CLD and 14 PRE were compared with 24 term controls (CON). The premature children had no overt manifestations of a neuromuscular disease.

Methods: Pulmonary function at rest and following exercise, and aerobic exercise performance were measured.

Results: Peak [latin capital V with dot above]O2 and maximal aerobic power were not different among the groups, but O2 uptake at a given mechanical power was higher in the CLD than in PRE and in CON (P < 0.05). At rest, forced vital capacity was significantly lower in CLD than in PRE (P < 0.05) and CON (P < 0.0005), and FEV1 and FEF25-75 were lower in CLD than CON (P < 0.0005 and P < 0.005, respectively). Exercise-induced bronchoconstriction (EIB) was more prevalent among the 2 premature groups (P < 0.05).

Conclusions: Our children 5 to 7 years old born at VLBW or ELBW, with or without CLD, have some degree of pulmonary dysfunction at rest and following exercise and a higher prevalence of EIB with no reduction in maximal aerobic exercise performance. The findings suggest that the pulmonary limitations are associated with low birthweight even in the absence of CLD. The higher O2 uptake at a given mechanical power in the CLD group may cause early fatigability during prolonged exercise, even when aerobic performance is normal.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.jsm.0000180023.44889.ddDOI Listing

Publication Analysis

Top Keywords

cld pre
12
cld
9
premature children
8
chronic lung
8
lung disease
8
children years
8
years born
8
low birthweight
8
rest exercise
8
exercise aerobic
8

Similar Publications

Liver damage and immune responses.

Z Gastroenterol

January 2025

Institut für Molekulare Immunologie, Technische Universität München, München, Germany.

Chronic liver disease (CLD) has massive systemic repercussions including major impacts on the body's immune system. Abnormalities in phenotype, function and numbers of various immune cell subsets have been established by a large number of clinical and pre-clinical studies. The loss of essential immune functions renders CLD-patients exceptionally susceptible to bacterial and viral infections and also impairs the efficacy of vaccination.

View Article and Find Full Text PDF
Article Synopsis
  • Ongoing research is essential for tracking and understanding the emergence of new SARS-CoV-2 variants, particularly as diagnostic testing declines in Australia during the COVID-19 pandemic.
  • In 2023, collaborations with pathology and genomics teams allowed for the monitoring of SARS-CoV-2 variants in New South Wales through various methods, including viral culture and analysis of immune responses from a large pool of blood donations.
  • Findings indicated that while existing antibodies generally neutralized many variants, specific mutations in emerging strains, particularly JN.1, suggested future challenges in controlling their spread due to enhanced transmissibility.
View Article and Find Full Text PDF

Background: Acute on Chronic Liver Failure (ACLF) complicates chronic liver disease (CLD) combining rapidly progressive hepatic with extra-hepatic multiple organ failure and high short-term mortality. Effective therapeutic options are very limited, and liver transplantation (LT) seldom utilised through concerns of high recipient mortality and resource use. Retrospective reports suggest recent outcomes may have improved, but use of LT for ACLF has not been prospectively assessed.

View Article and Find Full Text PDF

Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease.

Aliment Pharmacol Ther

February 2025

Division of Gastroenterology and Hepatology, Zuckerberg San Francisco General, San Francisco, California, USA.

Article Synopsis
  • Alcohol use is common among patients with chronic liver disease (CLD), and this study examined factors that affect their motivation to reduce drinking.
  • The study involved 121 participants from safety-net hospitals and Veterans Affairs systems, assessing their mental health, alcohol use, and motivation to decrease drinking through various questionnaires.
  • Results showed that depression and severity of alcohol problems were linked to higher motivation, while the treatment site impacted their importance score, indicating these factors should guide future interventions in hepatology care.
View Article and Find Full Text PDF

To review the findings of a multiparametric MRI (the "liver triple screen") solution for the non-invasive assessment of liver fat, iron, and fibrosis in patients with chronic liver disease (CLD). A retrospective evaluation of all consecutive triple screen MRI cases was performed at our institution over the last 32 months. Relevant clinical, laboratory, and radiologic data were analyzed using descriptive statistics.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!